BACK TO MAIN PAGE

 


©1994-2018 All Rights Reserved. Online Journal of Veterinary Research. You may not store these pages in any form except for your own personal use. All other usage or distribution is illegal under international copyright treaties. Permission to use any of these pages in any other way besides the  before mentioned must be gained in writing from the publisher. This article is exclusively copyrighted in its entirety to OJVR publications. This article may be copied once but may not be, reproduced or  re-transmitted without the express permission of the editors.


OJVRTM

Online Journal of Veterinary Research
 

Volume 4: 1-20, 2000. Redacted 2018.


A caprine breast model for testing a novel balloon brachytherapy device

 

J. Paul Spurlock, D.V.M., M.P.H. a, Robert R. Kuske, Jr., M.D. b, William J. McKinnon, M.D. c, Ed Moran, L.A.T.G. a, Laura Sabo, B.S. d and H. W. Taylor, D.V.M., Ph.D. e

 

a Department of Vivarial Science & Research, Tulane University School of Medicine, 1430 Tulane Avenue, New Orleans, LA 70112 b Department of Radiation Oncology, Ochsner Clinic and Tulane University School of Medicine, New Orleans, LA 70112 c Department of Surgery, Tulane University, School of Medicine, 1430 Tulane Avenue, New Orleans, LA 70112 d Proxima Therapeutics, Inc., 1111 Alderman Drive, Suite 280, Alpharetta, GA 30005 e Department of Pathology, Louisiana State University School of Veterinary Medicine, Baton Rouge, LA 70803Address for correspondence:  J. Paul Spurlock, D.V.M., M.P.H., Tulane University School of Medicine, Department of Vivarial Science & Research,SL62, 1430 Tulane Avenue, New Orleans, LA 70112. Email: pspurlo@tmcpop.tmc.tulane.edu

 

ABSTRACT

 

Spurlock JP, Kuske R,  McKinnon WJ,  Moran E,  Sabo L, Taylor HW A caprine breast model for testing a novel balloon brachytherapy device, Onl J Vet Res., 4: 1-20, 2000. We describe a caprine breast model developed to evaluate the Proxima GliaSite® applicator as a prototype device design for brachytherapy treatment after mammary tumor resection. Testing the novel interstitial balloon applicator required an animal breast model of appropriate size and structure to respond to lumpectomy (with or without device implantation) at gross and cellular levels comparable to human breast tissue. The model would need to allow the detection of seroma or hematoma formation, foreign-body reaction, or inflammation in response to the implanted device, as well as allow evaluation of balloon conformance and its effect on a lumpectomy cavity. The female goat was suggested as an appropriate animal model for this study because goat breast and mammary tissue characteristics can bear particular similarity to that of humans. The female goat was an excellent experimental subject within the construct of this study, and the caprine breast model proved well suited for evaluating the test device in vivo. Based on the results of this project, this breast model will be used in future studies to evaluate a balloon catheter device of similar design in conjunction with low-dose radiation (LDR) and high-dose radiation (HDR) boost therapy on mammary tissue after tumor resection.

 

KEY WORDS: Caprine breast model; goat animal model; mammary tumor resection; interstitial brachytherapy; boost therapy; balloon applicator; balloon catheter; GliaSite® ; Proxima


FULL-TEXT (SUBSCRIPTION OR PURCHASE ARTICLE

 

BACK TO MAIN PAGE